Cosmos Holdings
NASDAQ: COSMChicago, US · Nevada corporation
Founders & leadership
JJ
John J HoidasNamed on SEC filing
DG
Demetrios G DemetriadesNamed on SEC filing
DG
Dimitrios GoulielmosNamed on SEC filing
GS
Grigorios SiokasNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$44.3M disclosed across 5 rounds · 2017–2023
▶$5.3MraisedJul 2023 · 3 investors · PharmaceuticalsRule 506(b)
▶$5.3MraisedJul 2023 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anastasios AslidisDirector
- Grigorios SiokasExecutive Officer, Director
- John J. HoidasDirector
- Manfred ZieglerDirector
- Demetrios G. DemetriadesDirector
- Offering amount
- $5.3M
- Amount sold
- $5.3M
- Minimum investment
- $100K
- Sales commissions
- $310.4K
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Jul 2023
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$32.5MraisedJan 2023 · PharmaceuticalsRule 506(b)
▶$32.5MraisedJan 2023 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anastasios AslidisDirector
- Demetrios G. DemetriadesDirector
- Grigorios SiokasExecutive Officer, Director
- Manfred ZieglerDirector
- John J. HoidasDirector
- Offering amount
- $32.5M
- Amount sold
- $32.5M
- Minimum investment
- $100K
- Sales commissions
- $1.6M
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Dec 2022
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.5MraisedJun 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedJun 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John J HoidasDirector
- Demetrios G DemetriadesDirector
- Dimitrios GoulielmosDirector
- Grigorios SiokasExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $50K
- Sales commissions
- $90K
- Placement agents
- Roth Capital Partners LLC
- First sale
- May 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$2MraisedSep 2018 · 2 investors · PharmaceuticalsRule 506(b)
▶$2MraisedSep 2018 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Grigorios SiokasExecutive Officer, Director
- Dimitrios GoulielmosDirector
- Demetrios G DemetriadesDirector
- John J HoidasDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $500K
- Sales commissions
- $140K
- Placement agents
- Roth Capital Partners LLC
- First sale
- Sep 2018
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$3MraisedNov 2017 · 2 investors · PharmaceuticalsRule 506(b)
▶$3MraisedNov 2017 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John J HoidasDirector
- Demetrios G DemetriadesDirector
- Dimitrios GoulielmosDirector
- Grigorios SiokasExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $500K
- Sales commissions
- $240K
- Placement agents
- Roth Capital Partners LLC
- First sale
- Nov 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Cosmos Holdings raised?
- Cosmos Holdings has disclosed $44.3M raised across 5 rounds.
- Where is Cosmos Holdings headquartered?
- Cosmos Holdings is headquartered in Chicago, US.